Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Asian Journal of Surgery|September 6, 2023
Trimethylamine-N-oxide (TMAO) and predicted risk of cardiovascular events after partial nephrectomyXiangpeng Zou, Longbin Xiong, Zhixing Guo, et al.
Molecular Medicine Reports|September 10, 2015
Spironolactone inhibits podocyte motility via decreasing integrin β1 and increasing integrin β3 in podocytes under high-glucose conditionsZhuo Li, Li Zhang, Wei Shi, et al.
Biomaterials Research|December 5, 2022
Targeting treatment of bladder cancer using PTK7 aptamer-gemcitabine conjugateWei Xiang, Yongbo Peng, Hongliang Zeng, et al.
Kidney International|March 21, 2017
DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injuryLi Zhang, Qianmei Zhang, Shuangxin Liu, et al.
Iscience|September 4, 2023
Long-term effect of acute ischemic injury on the kidney underwent clamped partial nephrectomyZhaohui Zhou, Zhiyong Li, Kang Ning, et al.
Cancer Research|April 30, 2026
CRISPR Screening Reveals SAA1-Driven Neutrophil Extracellular Traps Promote CD8⁺ T Cell Dysfunction in Renal Cell CarcinomaXin Luo, Xiangpeng Zou, Yi Wu, et al.
Biomaterials Research|February 6, 2022
Treatment of bladder cancer by geoinspired synthetic chrysotile nanocarrier-delivered circPRMT5 siRNAChunping Yu, Yi Zhang, Ning Wang, et al.
International Journal of Surgery (London, England)|November 24, 2023
Longitudinal changes in renal parenchymal volume and function status after partial nephrectomy: a retrospective cohort studyLongbin Xiong, Xiangpeng Zou, Xin Luo, et al.
Biomaterials Research|December 15, 2025
Erratum to "Treatment of bladder cancer by geoinspired synthetic chrysotile nanocarrier-delivered circPRMT5 siRNA"Chunping Yu, Yi Zhang, Ning Wang, et al.
Biology of Sex Differences|September 15, 2023
Sex differences in renal cell carcinoma: a single-cell analysis reveals exhausted CD8+ T-cells highly infiltrated in malesKang Ning, Yulu Peng, Yue Jiang, et al.
Pageof 7